Columbus Circle Investors’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-10,151
Closed -$23.4M 182
2017
Q4
$23.4M Sell
10,151
-604
-6% -$1.23M 0.44% 88
2017
Q3
$19.1M Buy
10,755
+5,098
+90% +$7.12M 0.33% 98
2017
Q2
$7.7M Sell
5,657
-8,041
-59% -$9.7M 0.13% 143
2017
Q1
$16.1M Sell
13,698
-5,523
-29% -$5.63M 0.23% 114
2016
Q4
$15.4M Buy
19,221
+5,940
+45% +$4.72M 0.2% 106
2016
Q3
$11.7M Sell
13,281
-2,248
-14% -$1.63M 0.13% 144
2016
Q2
$8.71M Sell
15,529
-10,790
-41% -$6.11M 0.09% 179
2016
Q1
$14.5M Buy
26,319
+1,927
+8% +$1.18M 0.13% 149
2015
Q4
$20.3M Buy
24,392
+15,364
+170% +$15.3M 0.16% 135
2015
Q3
$10M Sell
9,028
-2,786
-24% -$5.08M 0.08% 192
2015
Q2
$25.8M Sell
11,814
-8,471
-42% -$17.3M 0.18% 137
2015
Q1
$31.7M Buy
20,285
+8,674
+75% +$11.4M 0.22% 111
2014
Q4
$13.8M Buy
11,611
+10,130
+684% +$6.77M 0.1% 177
2014
Q3
$688K Buy
+1,481
New +$683K ﹤0.01% 243

Other funds holding BLUE

Columbus Circle Investors's BLUE Position: Q1 2018 in Review

Columbus Circle Investors sold out of bluebird bio (BLUE) in Q1 2018, closing a stake of 10,151 shares — an estimated $23.4M sold.

Columbus Circle Investors first reported a position in BLUE in Q3 2014 and held it in 14 quarters. The position peaked at $31.7M in Q1 2015. 303 funds tracked by Wall St. Rank hold BLUE as of Q1 2018.

  • Columbus Circle Investors reported no remaining bluebird bio position as of Q1 2018 after selling out during the quarter.
  • Columbus Circle Investors sold 10,151 bluebird bio shares in Q1 2018, an estimated $23.4M.
  • Columbus Circle Investors first reported a position in bluebird bio in Q3 2014 and held it in 14 quarters.
  • Columbus Circle Investors's bluebird bio position peaked at $31.7M in Q1 2015.
  • 303 funds tracked by Wall St. Rank held bluebird bio as of Q1 2018.

Based on Columbus Circle Investors's 13F filing for Q1 2018, filed 9 May 2018.